Andrew J. Schwab sold $880k of CAMP
director at Camp4 Therapeutics Corp. 191,865 shares at an average of $4.59, traded Aug 19, 2026, filed Aug 21, 2026.
Score components
- +15RoleDirector
- +23Trade size$880k at market
- 0Share of holdings soldSold 7.3% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001598549-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | SOpen-market sale Common Stockindirect: By 5AM Ventures VI, L.P. | -45,147 | $4.76 | $215k | 2,579,998 | Aug 21, 2026 |
| Aug 20, 2026 | SOpen-market sale Common Stockindirect: By 5AM Ventures VI, L.P. | -114,700 | $4.54 | $521k | 2,465,298 | Aug 21, 2026 |
| Aug 21, 2026 | SOpen-market sale Common Stockindirect: By 5AM Ventures VI, L.P. | -32,018 | $4.50 | $144k | 2,433,280 | Aug 21, 2026 |
Related signals
Other insiders at Camp4 Therapeutics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | CAMPbuy Camp4 Therapeutics Corp | Kelly Gold Chief Financial Officer | $40k 10,000 shares | - | |
| 53Moderate | Camp4 Therapeutics Corp | Andrew J. Schwab director | $1.6M 400,000 shares | -16% | |
| 23Weak | Camp4 Therapeutics Corp | Andrew J. Schwab director | $45 10 shares | -0% | |
| 43Moderate | Camp4 Therapeutics Corp | Daniel Tardiff Chief Scientific Officer | $8,273 1,738 shares | -100% | |
| 48Moderate | Camp4 Therapeutics Corp | Josh Mandel-Brehm Chief Executive Officer | $11k 6,551 shares | +2% | |
| 48Moderate | Camp4 Therapeutics Corp | Kelly Gold Chief Financial Officer | $11k 6,551 shares | +10% | |
| 48Moderate | Camp4 Therapeutics Corp | Yuri Maricich Chief Medical Officer | $11k 6,551 shares | +108% | |
| 46Moderate | Camp4 Therapeutics Corp | Richard A Young director | $27k 16,378 shares | +10% | |
| 63Notable | Camp4 Therapeutics Corp | 5AM Partners VI, LLC owner | $4.5M 2,941,176 shares | - | |
| 73Notable | Camp4 Therapeutics Corp | Amir Nashat director, owner | $2.0M 1,307,189 shares | +82% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.